So am I swordfish. This was a nice update but was very general in content and that was fine with me. I liked hearing of the additional physiological ailments they are in the process of testing for possible future clearances. Every additional clearance undoubtedly adds more value ($$) to the company and its PEMF products. But no specifics or comp[any names were mentioned and that is understandable if there really are NDA's in place. IMO there are NDA's and when any deals with future OEM's are finalized and contracted, I'm sure we will be get that in a PR in early 2022. In the meantime it sounds like 'all systems go'!
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links